D2/3 Agonist during Learning Potentiates Cued Risky Choice

Impulse control and/or gambling disorders can be triggered by dopamine agonist therapies used to treat Parkinson's disease, but the cognitive and neurobiological mechanisms underlying these adverse effects are unknown. Recent data show that adding win-paired sound and light cues to the rat gamb...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of neuroscience Vol. 43; no. 6; pp. 979 - 992
Main Authors Mortazavi, Leili, Hynes, Tristan J, Chernoff, Chloe S, Ramaiah, Shrishti, Brodie, Hannah G, Russell, Brittney, Hathaway, Brett A, Kaur, Sukhbir, Winstanley, Catharine A
Format Journal Article
LanguageEnglish
Published Baltimore Society for Neuroscience 08.02.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Impulse control and/or gambling disorders can be triggered by dopamine agonist therapies used to treat Parkinson's disease, but the cognitive and neurobiological mechanisms underlying these adverse effects are unknown. Recent data show that adding win-paired sound and light cues to the rat gambling task (rGT) potentiates risky decision-making and impulsivity via the dopamine system, and that changing dopaminergic tone has a greater influence on behavior while subjects are learning task contingencies. Dopamine agonist therapy may therefore be potentiating risk-taking by amplifying the behavioral impact of gambling-related cues on novel behavior. Here, we show that ropinirole treatment in male rats transiently increased motor impulsivity but robustly and progressively increased choice of the high-risk/high-reward options when administered during acquisition of the cued but not uncued rGT. Early in training, ropinirole increased win-stay behavior after large unlikely wins on the cued rGT, indicative of enhanced model-free learning, which mediated the drug's effect on later risk preference. Ex vivo cFos imaging showed that both chronic ropinirole and the addition of win-paired cues suppressed the activity of dopaminergic midbrain neurons. The ratio of midbrain:prefrontal cFos+ neurons was lower in animals with suboptimal choice patterns and tended to predict risk preference across all rats. Network analyses further suggested that ropinirole induced decoupling of the dopaminergic cells of the VTA and nucleus accumbens but only when win-paired cues were present. Frontostriatal activity uninformed by the endogenous dopaminergic teaching signal therefore appeared to perpetuate risky choice, and ropinirole exaggerated this disconnect in synergy with reward-paired cues.
AbstractList Impulse control and/or gambling disorders can be triggered by dopamine agonist therapies used to treat Parkinson's disease, but the cognitive and neurobiological mechanisms underlying these adverse effects are unknown. Recent data show that adding win-paired sound and light cues to the rat gambling task (rGT) potentiates risky decision-making and impulsivity via the dopamine system, and that changing dopaminergic tone has a greater influence on behavior while subjects are learning task contingencies. Dopamine agonist therapy may therefore be potentiating risk-taking by amplifying the behavioral impact of gambling-related cues on novel behavior. Here, we show that ropinirole treatment in male rats transiently increased motor impulsivity but robustly and progressively increased choice of the high-risk/high-reward options when administered during acquisition of the cued but not uncued rGT. Early in training, ropinirole increased win-stay behavior after large unlikely wins on the cued rGT, indicative of enhanced model-free learning, which mediated the drug's effect on later risk preference. Ex vivo cFos imaging showed that both chronic ropinirole and the addition of win-paired cues suppressed the activity of dopaminergic midbrain neurons. The ratio of midbrain:prefrontal cFos+ neurons was lower in animals with suboptimal choice patterns and tended to predict risk preference across all rats. Network analyses further suggested that ropinirole induced decoupling of the dopaminergic cells of the VTA and nucleus accumbens but only when win-paired cues were present. Frontostriatal activity uninformed by the endogenous dopaminergic teaching signal therefore appeared to perpetuate risky choice, and ropinirole exaggerated this disconnect in synergy with reward-paired cues.
Impulse control and/or gambling disorders can be triggered by dopamine agonist therapies used to treat Parkinson's disease, but the cognitive and neurobiological mechanisms underlying these adverse effects are unknown. Recent data show that adding win-paired sound and light cues to the rat gambling task (rGT) potentiates risky decision-making and impulsivity via the dopamine system, and that changing dopaminergic tone has a greater influence on behavior while subjects are learning task contingencies. Dopamine agonist therapy may therefore be potentiating risk-taking by amplifying the behavioral impact of gambling-related cues on novel behavior. Here, we show that ropinirole treatment in male rats transiently increased motor impulsivity but robustly and progressively increased choice of the high-risk/high-reward options when administered during acquisition of the cued but not uncued rGT. Early in training, ropinirole increased win-stay behavior after large unlikely wins on the cued rGT, indicative of enhanced model-free learning, which mediated the drug's effect on later risk preference. Ex vivo cFos imaging showed that both chronic ropinirole and the addition of win-paired cues suppressed the activity of dopaminergic midbrain neurons. The ratio of midbrain:prefrontal cFos + neurons was lower in animals with suboptimal choice patterns and tended to predict risk preference across all rats. Network analyses further suggested that ropinirole induced decoupling of the dopaminergic cells of the VTA and nucleus accumbens but only when win-paired cues were present. Frontostriatal activity uninformed by the endogenous dopaminergic teaching signal therefore appeared to perpetuate risky choice, and ropinirole exaggerated this disconnect in synergy with reward-paired cues. SIGNIFICANCE STATEMENT D 2/3 receptor agonists, used to treat Parkinson's disease, can cause gambling disorder through an unknown mechanism. Ropinirole increased risky decision-making in rats, but only when wins were paired with casino-inspired sounds and lights. This was mediated by increased win-stay behavior after large unlikely wins early in learning, indicating enhanced model-free learning. cFos imaging showed that ropinirole suppressed activity of midbrain dopamine neurons, an effect that was mimicked by the addition of win-paired cues. The degree of risky choice rats exhibited was uniquely predicted by the ratio of midbrain dopamine:PFC activity. Depriving the PFC of the endogenous dopaminergic teaching signal may therefore drive risky decision-making on-task, and ropinirole acts synergistically with win-paired cues to amplify this.
Impulse control and/or gambling disorders can be triggered by dopamine agonist therapies used to treat Parkinson's disease, but the cognitive and neurobiological mechanisms underlying these adverse effects are unknown. Recent data show that adding win-paired sound and light cues to the rat gambling task (rGT) potentiates risky decision-making and impulsivity via the dopamine system, and that changing dopaminergic tone has a greater influence on behavior while subjects are learning task contingencies. Dopamine agonist therapy may therefore be potentiating risk-taking by amplifying the behavioral impact of gambling-related cues on novel behavior. Here, we show that ropinirole treatment in male rats transiently increased motor impulsivity but robustly and progressively increased choice of the high-risk/high-reward options when administered during acquisition of the cued but not uncued rGT. Early in training, ropinirole increased win-stay behavior after large unlikely wins on the cued rGT, indicative of enhanced model-free learning, which mediated the drug's effect on later risk preference. Ex vivo cFos imaging showed that both chronic ropinirole and the addition of win-paired cues suppressed the activity of dopaminergic midbrain neurons. The ratio of midbrain:prefrontal cFos+ neurons was lower in animals with suboptimal choice patterns and tended to predict risk preference across all rats. Network analyses further suggested that ropinirole induced decoupling of the dopaminergic cells of the VTA and nucleus accumbens but only when win-paired cues were present. Frontostriatal activity uninformed by the endogenous dopaminergic teaching signal therefore appeared to perpetuate risky choice, and ropinirole exaggerated this disconnect in synergy with reward-paired cues.SIGNIFICANCE STATEMENT D2/3 receptor agonists, used to treat Parkinson's disease, can cause gambling disorder through an unknown mechanism. Ropinirole increased risky decision-making in rats, but only when wins were paired with casino-inspired sounds and lights. This was mediated by increased win-stay behavior after large unlikely wins early in learning, indicating enhanced model-free learning. cFos imaging showed that ropinirole suppressed activity of midbrain dopamine neurons, an effect that was mimicked by the addition of win-paired cues. The degree of risky choice rats exhibited was uniquely predicted by the ratio of midbrain dopamine:PFC activity. Depriving the PFC of the endogenous dopaminergic teaching signal may therefore drive risky decision-making on-task, and ropinirole acts synergistically with win-paired cues to amplify this.Impulse control and/or gambling disorders can be triggered by dopamine agonist therapies used to treat Parkinson's disease, but the cognitive and neurobiological mechanisms underlying these adverse effects are unknown. Recent data show that adding win-paired sound and light cues to the rat gambling task (rGT) potentiates risky decision-making and impulsivity via the dopamine system, and that changing dopaminergic tone has a greater influence on behavior while subjects are learning task contingencies. Dopamine agonist therapy may therefore be potentiating risk-taking by amplifying the behavioral impact of gambling-related cues on novel behavior. Here, we show that ropinirole treatment in male rats transiently increased motor impulsivity but robustly and progressively increased choice of the high-risk/high-reward options when administered during acquisition of the cued but not uncued rGT. Early in training, ropinirole increased win-stay behavior after large unlikely wins on the cued rGT, indicative of enhanced model-free learning, which mediated the drug's effect on later risk preference. Ex vivo cFos imaging showed that both chronic ropinirole and the addition of win-paired cues suppressed the activity of dopaminergic midbrain neurons. The ratio of midbrain:prefrontal cFos+ neurons was lower in animals with suboptimal choice patterns and tended to predict risk preference across all rats. Network analyses further suggested that ropinirole induced decoupling of the dopaminergic cells of the VTA and nucleus accumbens but only when win-paired cues were present. Frontostriatal activity uninformed by the endogenous dopaminergic teaching signal therefore appeared to perpetuate risky choice, and ropinirole exaggerated this disconnect in synergy with reward-paired cues.SIGNIFICANCE STATEMENT D2/3 receptor agonists, used to treat Parkinson's disease, can cause gambling disorder through an unknown mechanism. Ropinirole increased risky decision-making in rats, but only when wins were paired with casino-inspired sounds and lights. This was mediated by increased win-stay behavior after large unlikely wins early in learning, indicating enhanced model-free learning. cFos imaging showed that ropinirole suppressed activity of midbrain dopamine neurons, an effect that was mimicked by the addition of win-paired cues. The degree of risky choice rats exhibited was uniquely predicted by the ratio of midbrain dopamine:PFC activity. Depriving the PFC of the endogenous dopaminergic teaching signal may therefore drive risky decision-making on-task, and ropinirole acts synergistically with win-paired cues to amplify this.
Author Chernoff, Chloe S
Ramaiah, Shrishti
Kaur, Sukhbir
Russell, Brittney
Winstanley, Catharine A
Mortazavi, Leili
Brodie, Hannah G
Hathaway, Brett A
Hynes, Tristan J
Author_xml – sequence: 1
  givenname: Leili
  surname: Mortazavi
  fullname: Mortazavi, Leili
– sequence: 2
  givenname: Tristan
  surname: Hynes
  middlename: J
  fullname: Hynes, Tristan J
– sequence: 3
  givenname: Chloe
  surname: Chernoff
  middlename: S
  fullname: Chernoff, Chloe S
– sequence: 4
  givenname: Shrishti
  surname: Ramaiah
  fullname: Ramaiah, Shrishti
– sequence: 5
  givenname: Hannah
  surname: Brodie
  middlename: G
  fullname: Brodie, Hannah G
– sequence: 6
  givenname: Brittney
  surname: Russell
  fullname: Russell, Brittney
– sequence: 7
  givenname: Brett
  surname: Hathaway
  middlename: A
  fullname: Hathaway, Brett A
– sequence: 8
  givenname: Sukhbir
  surname: Kaur
  fullname: Kaur, Sukhbir
– sequence: 9
  givenname: Catharine
  surname: Winstanley
  middlename: A
  fullname: Winstanley, Catharine A
BookMark eNpdj8tOwzAQRS1URB_wCygSGzZpx4_EDgukKhQoqigqdB3ZidO6pHaJE6T-PUGwgdXM6B4dzR2innVWI3SJYYwjQidPz7P1avmazseYRUlIyJgAISdo0KXdyQD30AAIhzBmnPXR0PsdAHDA_Az1aRwTKng8QDd3ZEKD6cZZ45ugaGtjN8FCy9p-Ly-u0bYxstE-SFtdBCvj349BunUm1-fotJSV1xe_c4TW97O39DFcLB_m6XQRHgjHTVjmmjEQuVCYERGXPJe4gDgCThJRRkxJqogqCipAFUmpIqWkiCgkhNGISUVH6PbHe2jVXhd591Etq-xQm72sj5mTJvubWLPNNu4zSxIQFItOcP0rqN1Hq32T7Y3PdVVJq13rM8JjSinDmHXo1T9059radvU6iscEIAFKvwA603JK
ContentType Journal Article
Copyright Copyright Society for Neuroscience Feb 8, 2023
Copyright © 2023 the authors.
Copyright © 2023 the authors 2023
Copyright_xml – notice: Copyright Society for Neuroscience Feb 8, 2023
– notice: Copyright © 2023 the authors.
– notice: Copyright © 2023 the authors 2023
DBID 7QG
7QR
7TK
7U7
7U9
8FD
C1K
FR3
H94
P64
7X8
5PM
DOI 10.1523/JNEUROSCI.1459-22.2022
DatabaseName Animal Behavior Abstracts
Chemoreception Abstracts
Neurosciences Abstracts
Toxicology Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle Virology and AIDS Abstracts
Technology Research Database
Toxicology Abstracts
Animal Behavior Abstracts
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList Virology and AIDS Abstracts

MEDLINE - Academic
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1529-2401
EndPage 992
ExternalDocumentID PMC9908318
GrantInformation_xml – fundername: Stanford Department of Psychology
– fundername: ;
  grantid: CGS-M
– fundername: Canadian Institute for Health Research (CIHR)
  grantid: PJT-162312; FBD-170900
GroupedDBID ---
-DZ
-~X
.55
18M
2WC
34G
39C
53G
5GY
5RE
5VS
7QG
7QR
7TK
7U7
7U9
8FD
AAFWJ
AAJMC
ABBAR
ABIVO
ACGUR
ACNCT
ADBBV
ADHGD
AENEX
AFCFT
AFOSN
AFSQR
AHWXS
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
C1K
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
FR3
GX1
H13
H94
HYE
H~9
KQ8
L7B
OK1
P0W
P2P
P64
QZG
R.V
RHI
RPM
TFN
TR2
W8F
WH7
WOQ
X7M
YBU
YHG
YKV
YNH
YSK
7X8
5PM
ID FETCH-LOGICAL-p271t-fce4408c8b14286f7ca1d06507298f54ba3b2bdd380bd9fb5bba8530924354ab3
ISSN 0270-6474
1529-2401
IngestDate Thu Aug 21 18:41:55 EDT 2025
Sun Aug 24 03:39:24 EDT 2025
Mon Jun 30 16:42:30 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License SfN exclusive license.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p271t-fce4408c8b14286f7ca1d06507298f54ba3b2bdd380bd9fb5bba8530924354ab3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Author contributions: L.M. and C.A.W. designed research; L.M., T.J.H., C.S.C., S.R., H.G.B., B.R., B.A.H. and S.K. performed research; L.M. analyzed data; L.M. wrote the first draft of the paper; L.M. and C.A.W. edited the paper; L.M. and C.A.W. wrote the paper.
ORCID 0000-0002-1905-2199
0000-0001-9838-4935
0000-0001-7032-4471
PMID 36623876
PQID 2776200903
PQPubID 2049535
PageCount 14
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9908318
proquest_miscellaneous_2763334114
proquest_journals_2776200903
PublicationCentury 2000
PublicationDate 20230208
PublicationDateYYYYMMDD 2023-02-08
PublicationDate_xml – month: 02
  year: 2023
  text: 20230208
  day: 08
PublicationDecade 2020
PublicationPlace Baltimore
PublicationPlace_xml – name: Baltimore
PublicationTitle The Journal of neuroscience
PublicationYear 2023
Publisher Society for Neuroscience
Publisher_xml – name: Society for Neuroscience
SSID ssj0007017
Score 2.4661293
Snippet Impulse control and/or gambling disorders can be triggered by dopamine agonist therapies used to treat Parkinson's disease, but the cognitive and...
SourceID pubmedcentral
proquest
SourceType Open Access Repository
Aggregation Database
StartPage 979
SubjectTerms Agonists
Choice learning
Cognitive ability
Cognitive tasks
Decision making
Decoupling
Dopamine
Dopamine D2 receptors
Gambling
Impulsive behavior
Impulsivity
Learning
Mental task performance
Mesencephalon
Movement disorders
Neurodegenerative diseases
Neurons
Nucleus accumbens
Parkinson's disease
Risk
Risk taking
Title D2/3 Agonist during Learning Potentiates Cued Risky Choice
URI https://www.proquest.com/docview/2776200903
https://www.proquest.com/docview/2763334114
https://pubmed.ncbi.nlm.nih.gov/PMC9908318
Volume 43
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkNBe0GAgygYyEuKlSpfGufJWZaAxWDXWTtpbZTcOjViTakuRtt_Cj-Uc27mNPcBeoirOrTlfjj_b53yHkPcpSxI38VLLdhNmgZcMrTBNIouLwPc94TlBgInCJxP_6Nw9vvAuer3frailTSmGi9t780oeYlXYB3bFLNn_sGx9UdgBv8G-sAULw_afbHyIsqZsMP5RoP5tlXL4rZrtOC1KjAVCNjmIN8Asz7Lrn6hmXJiAt4qVNvlhipm2NC6byFik6bf8l06mltllVgPixqj9z9BfYDbUsIkZkFd5oXUf4-VlIQfTuu2Mr3jG1aTOFAUOlmXWnoFwmApaDpsZyFZ46eTuA2pP5gQwRnV1OZ6hNJ7WUUs7o7Yr1opNBnJtvxrpijOmi450-by_vL-nVCiOJxgEOY2_QC_gwT0w3c7pnABWXK8UJpgP9C8M7ohxq-799CSGnjoEn_eIPAbIOlgf4-v3Ros-sFU95_rPmfxzeIiD-x9hmzyp7tcZz3SjcVv0ZrZDnhrr07EG2TPSk_lzsjvOeVmsbugHqiKF1RLMLvl46BwwalBHNepohTraQh1F1FGFOqpR94Kcf_40i48sU4PDWjvBqLTShcSa5IsQJwtDPw0WfJQgrYdBWZh6ruBMOCJJWGiLJEqFJwQHBmjDsJ55LhfsJdnKi1y-IpTDgcDXZWoDiZc-XFKwSOL6krvggIQ-2a_eydx8ZNdzePE-LuDZrE_e1c3gAnFdi-ey2OAxPmPAxkZunwSddzlfa8mWOYqod1vybKnE1I2NXz_4zD2y3XwU-2SrvNrIN0BUS_FW4eUPZA-TyQ
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=D2%2F3+Agonist+during+Learning+Potentiates+Cued+Risky+Choice&rft.jtitle=The+Journal+of+neuroscience&rft.au=Mortazavi%2C+Leili&rft.au=Hynes%2C+Tristan+J.&rft.au=Chernoff%2C+Chloe+S.&rft.au=Ramaiah%2C+Shrishti&rft.date=2023-02-08&rft.pub=Society+for+Neuroscience&rft.issn=0270-6474&rft.eissn=1529-2401&rft.volume=43&rft.issue=6&rft.spage=979&rft.epage=992&rft_id=info:doi/10.1523%2FJNEUROSCI.1459-22.2022&rft_id=info%3Apmid%2F36623876&rft.externalDocID=PMC9908318
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-6474&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-6474&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-6474&client=summon